Evidence map›Paper›PMID 28261216›Full record

ArticleFrontiers in immunology2017

Smoothened Regulates Migration of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis

Wei-Xiang Peng, Shang-Ling Zhu, Bai-Yu Zhang, Yi-Ming Shi, Xiao-Xue Feng, Fang Liu, Jian-Lin Huang, Song Guo Zheng

RetractedAbstract readRetracted Publication
In one paragraph

Article in Frontiers in immunology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. A protocol for humanized synovitis mice model.American journal of clinical and experimental immunology · 2019
    Article
  12. Article
  13. Article
  14. Apremilast Ameliorates Experimental ArthritisFrontiers in immunology · 2018
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Wei-Xiang PengDivision of Rheumatology, Department of Internal Medicine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Department of for Clinical Immunology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Division of Nephrology, Zhuhai People's Hospital, Zhuhai, China.
Shang-Ling ZhuDivision of Rheumatology, Department of Internal Medicine, The Sixth Affiliated Hospital, Sun Yat-sen University , Guangzhou , China.
Bai-Yu ZhangDivision of Rheumatology, Department of Internal Medicine, The Sixth Affiliated Hospital, Sun Yat-sen University , Guangzhou , China.
Yi-Ming ShiDivision of Rheumatology, Department of Internal Medicine, The Sixth Affiliated Hospital, Sun Yat-sen University , Guangzhou , China.
Xiao-Xue FengDivision of Rheumatology, Department of Internal Medicine, The Sixth Affiliated Hospital, Sun Yat-sen University , Guangzhou , China.
Fang LiuDivision of Rheumatology, Department of Internal Medicine, The Third Affiliated Hospital, Sun Yat-sen University , Guangzhou , China.
Jian-Lin HuangDivision of Rheumatology, Department of Internal Medicine, The Sixth Affiliated Hospital, Sun Yat-sen University , Guangzhou , China.
Song Guo ZhengDepartment of for Clinical Immunology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China; Division of Rheumatology, Department of Medicine, Milton S. Hershey Medical Center, Hershey, PA, USA.

Funding

Therapeutic immunoregulation mediated by TGF-??-induced iTregs in autoimmune arthR01AR059103 · NIAMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI JARJOUR, WAEL N · 2010 to 2020
$3.9M
Mesenchymal Stem Cells Derived from Human Gingiva (GMSC) Inhibit Bone Erosion in Autoimmune ArthritisR61AR073049 · NIAMS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI ZHENG, SONG GUO · 2017 to 2018
$767k
NIAMS NIH HHS R01 AR059103NIAMS NIH HHS R61 AR073049
6 · The paper itself

Abstract

Fibroblast-like synoviocytes (FLSs) acquire aggressive phenotypes characterized with enhanced migration abilities and inherent invasive qualities in rheumatoid arthritis (RA). Smoothened (Smo) is a key component of sonic hedgehog (Shh) signaling and contributes to tumor cell invasion and metastasis. The objective of this study is to investigate the role of Smo in the modulation of cell migration and explore the underlying molecular mechanism(s). FLSs were isolated from RA synovium. Shh levels were regulated by a Smo agonist (purmorphamine), Smo antagonist (KAAD-cyclopamine), or small interfering RNA targeting the Smo gene (Smo-siRNA) in RA-FLSs. Expression of Smo was detected by real-time PCR and western blot analysis. Cell migration was examined by Transwell assay and activation of Rho GTPases was measured by pull-down assays. Incubation with purmorphamine resulted in a significant increase of cell migration and activation of Rho GTPase signaling compared to controls (

Indexed as

fibroblast-like synoviocytemigrationrheumatoid arthritissmoothened proteinsonic hedgehog signaling

Identifiers

PMID28261216
PMCPMC5309251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.